Abrilada® (adalimumab-afzb)
for Psoriasis

Abrilada (adalimumab-afzb) is a biosimilar of Humira. It is used to treat various autoimmune conditions, including, but not limited to rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. Abrilada helps reduce pain, inflammation, and skin symptoms by inhibiting TNF-alpha, a protein involved in the inflammatory process. It belongs to the class of TNF blockers (TNF alpha inhibitors).

Heart
Other top medicines used to treat Psoriasis